Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma
- PMID: 12909217
- DOI: 10.1016/s0360-3016(03)00507-8
Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma
Abstract
Purpose: To investigate the importance of total treatment time on the outcome of external beam radiotherapy (EBRT) followed by internal brachytherapy for the treatment of oral tongue carcinoma.
Methods and materials: Ninety-four patients with T1-T2N0 squamous cell carcinoma of the oral tongue were treated using 35-40 Gy EBRT followed by 35-40 Gy interstitial (137)Cs brachytherapy between 1985 and 1995. The interval between the end of EBRT and the start of interstitial treatment varied for numerous unavoidable reasons, with a mean of 25.3 days and standard deviation of 3.5 days. The median follow-up period was 59.1 months (range 6-146).
Results: The actuarial survival rate of all cases was 78.4% at 5 years. The 5-year local control rate for those with T1 and T2 was 92.8% and 62.7%, respectively (p < 0.05). The local control rate of the primary tumor in patients with a total treatment time >43 days was statistically lower than that of patients with a total treatment time < or =43 days in all patients (p < 0.05) and in the subgroup of Stage T2 patients (p < 0.05). Multivariate analysis revealed that the local control rates in all cases were significantly related to the T stage (T2 or not), total treatment time (>43 days or not), and location of disease (posterior or not). Regression analysis for 5-year local control as a function of treatment duration showed a 2% loss of local control per day of treatment extension >30 days (r = 0.94, p < 0.01).
Conclusion: The total treatment time was associated with the local control rate in the RT of oral tongue carcinoma. The loss in local control was estimated to be 2.0% per additional day in our series for oral tongue carcinoma.
Similar articles
-
Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):767-75. doi: 10.1016/s0360-3016(99)00068-1. Int J Radiat Oncol Biol Phys. 1999. PMID: 10386633
-
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy.Int J Radiat Oncol Biol Phys. 1990 Jun;18(6):1287-92. doi: 10.1016/0360-3016(90)90299-y. Int J Radiat Oncol Biol Phys. 1990. PMID: 2370178
-
Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.Radiother Oncol. 1994 Jun;31(3):199-206. doi: 10.1016/0167-8140(94)90424-3. Radiother Oncol. 1994. PMID: 8066202
-
[ORL brachytherapy. Brachytherapy of epidermoid carcinoma of the oral cavity].Bull Cancer Radiother. 1995;82(2):186-90. Bull Cancer Radiother. 1995. PMID: 7546889 Review. French. No abstract available.
-
Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.Radiother Oncol. 1991 May;21(1):39-47. doi: 10.1016/0167-8140(91)90339-i. Radiother Oncol. 1991. PMID: 1852918 Review.
Cited by
-
Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.Clin Transl Oncol. 2009 May;11(5):302-11. doi: 10.1007/s12094-009-0358-2. Clin Transl Oncol. 2009. PMID: 19451063
-
Cesium implant for tongue carcinoma with a thickness of 1.5 cm or more: cases successfully treated with a Modified Manchester System.Yonsei Med J. 2010 Jul;51(4):557-61. doi: 10.3349/ymj.2010.51.4.557. Yonsei Med J. 2010. PMID: 20499422 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources